PositiveID Corporation Adds Olympian Gary Hall, Jr. as Advisor to Expand Its Diabetes Initiatives

And Satan claims another soul!


PositiveID Corporation (“PositiveID”) (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today that it has added Olympian Gary Hall, Jr. as an advisor to maximize the Company’s diabetic initiatives. Hall, who has type-1 diabetes and is celebrity advocate for the Juvenile Diabetes Research Foundation (JDRF), has testified in front of Congress on current healthcare issues, campaigned for diabetes awareness, headed patient compliance efforts, patient outreach programming, education initiatives, and fundraising efforts for important diabetes research.

Internationally recognized for medaling in three Olympics, despite having diabetes, Gary Hall, Jr. is an active diabetes industry consultant with vast experience working in the healthcare industry. He is an international lecturer with a highly developed media presence and a key opinion leader on diabetes and its impact on society. A distinguished humanitarian award recipient for his outreach work achievement through national and international campaigns Gary has established vast networks in healthcare, the International Olympic movement, media, politics and industry.

Hall stated, “I am eager and excited to help PositiveID maximize the potential reach of their innovative diabetes management products. As a person living with diabetes and as an elite athlete, I know the importance of blood glucose management and awareness. The Company is taking the management of this devastating chronic illness to a new level, and together, I believe we can make important in-roads in diabetes care.”

Scott R. Silverman, Chairman and CEO of PositiveID, said, “We believe the addition of Gary Hall, Jr., one of the world’s most highly decorated and recognized Olympic athletes and a key opinion leader on diabetes issues, as an advisor for PositiveID will help us as we continue our development and prepare to bring diabetes management products to market, both from a business and a patient perspective. We will utilize Gary’s extensive knowledge about this disease and the strong contacts he has in order to establish additional beneficial relationships in the diabetes market.”

Leave a Reply